Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haimix is an amino acid mixture developed by KrasPharma for parenteral nutrition. It is designed to provide essential and non-essential amino acids to patients who cannot receive adequate nutrition orally or enterally. The product is administered intravenously and is indicated for various conditions requiring parenteral nutritional support. It has successfully completed all required preclinical and clinical protocols in Russia, indicating its status as an approved or marketed product in that region. As a parenteral nutrition product, it functions by providing the necessary substrates for protein synthesis and maintaining nitrogen balance in patients with compromised gastrointestinal function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Haimix.